Solutions
Advisory Services
Clinical Development
- Generics Development
- Clinical Operations
- Clinical Data Sciences
- Medical and Safety Services
- RWD & RWE Services
Post Marketing
- Safety Services
- Post marketing Studies
- Regulatory Affairs
How Navitas Life Sciences grew to be a Strategic Partner for Top Pharma across the World Clinical trials are the backbone of modern medical advancements, driving the development of new treatments and therapies that improve patient lives. For the past three decades, Navitas Life Sciences has been at the forefront of supporting and transforming the c...
The global clinical trials market, valued at USD 80.7 billion in 2023, is projected to grow at a compound annual growth rate (CAGR) of 6.49% from 2024 to 2030. This expansion highlights the critical importance of selecting the right Contract Research Organization (CRO) to manage efficient and compliant clinical trials. In our latest blog, we discus...
By reimagining regulatory submission strategies with artificial intelligence in regulatory affairs, pharmaceutical companies can expedite timelines and boost their chances of successful product approvals. To accelerate the market entry of new products, there is a need to increasingly focus on regulatory submissions as a critical area for developing...
At Navitas Life Sciences, we believe in not just advancing the frontiers of pharmaceutical sciences but also in giving back to society and academia. Dr Latika Sharma, MBBS., MD, our PV Networks Lead, led an insightful seminar as a part of clinical research & pharmacovigilance training on “Pharmacovigilance: Trends, Opportunities & Ch...
In the fight against counterfeit medicines, the stakes are incredibly high. Counterfeit drugs pose significant threats to public health worldwide, with far-reaching consequences, especially in regions with limited regulatory oversight. At Navitas Life Sciences, we are dedicated to addressing these challenges head-on. Recently, Dr. Philipp Hofmann, ...
“Congratulations on the PMDA approval, that is a huge accomplishment. The submission would never have been possible without your hard work and dedication. Thank you.” Senior Director, Biostatistics Programming, Global Biopharmaceutical Company talking about our Global FSP solutions. Expertise, hard work, dedication, and high quality h...
Patient-centric clinical trials, which are likely to be more efficient, productive, and engaging with patients and their needs, are at the forefront of Navitas Life Sciences' approach. The Society for Clinical Trials (SCT) 2024 theme, 'It takes a village: Patient-centered partnerships in clinical trials,' resonates deeply with us. As one of the lea...
In clinical research, efficiency and quality are key. As the industry continues to grow, Functional Service Provider (FSP) models are gaining popularity for their ability to streamline operations and provide specialized services. As a leading CRO, Navitas Life Sciences also offers robust FSP services that can enhance the efficiency and outcomes of ...
As a sought-after infectious disease and vaccine CRO, Navitas Life Sciences recognizes that vaccines continue to be one of the most powerful tools for disease prevention, safeguarding communities against a wide range of infectious diseases. Behind every successful vaccine, there lies a rigorous process of research, development, and testing through ...
As we celebrate World Health Day, it's crucial to recognize the pivotal role that technology, particularly Artificial Intelligence (AI), plays in advancing healthcare, particularly in clinical trials. When is World health Day? World health Day is Celebrated on April 7th every year, highlighting the importance of quality health care. This World heal...